Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : NKTR Drug delivery Company -- Ignore unavailable to you. Want to Upgrade?

To: tuck who wrote (7)	12/20/2005 10:37:02 AM
From: david nordic	Read Replies (2) \| Respond to of 507

Given that backdrop of slow, steady acceptance, I expect slow, steady share price appreciation -- for a biotech, meaning there will be some volatility in the uptrend. Thus, I think this makes a pretty good long term covered call candidate, and that is how I am playing it. Cheers, Tuck The whole ball of wax. Slow ramp. I think the acceptance will be much higher. Type II who are on insulin can not go back to pills. No option. Insulin is a given. With Exubera there is a choice. There is an option. Inhaled Insulin vs Injected insulin. One yahoo poster said "Smoking is inhaled into the lungs and the FDA has not banned smoking" We wait. David